The S&P 500 already rose more than 20% from its bear market low — now, it just has to reach a new high, and the next bull market will begin. Here, Motley Food contributors Adria Cimino and Keith Speights discuss two favorites — CRISPR Therapeutics (NASDAQ: CRSP) and Medtronic (NYSE: MDT) — that could be entering a new era of growth. Which makes the best bull market buy?
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles